Skip to main content
Clinical Trials/IRCT201011205206N1
IRCT201011205206N1CompletedPhase 3

Evaluation of Mint efficacy on primary dysmenorrhea in comparison with Mefnamic Acid

Hamadan University of Medical Sciences0 sites432 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
432

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 25 years (—)
Sex
Female

Inclusion Criteria

  • Inclusion Criteria: a) Primary dysmenorrhea; b) Single; c) 18-25 years old.
  • Exclusion criteria: a) Contraindication of mint including obstruction of common bile duct, allergy, cholecystitis, chronic liver disease, and gastroesophageal reflux, b) contraindication of mefenamic acid including: allergy, gastritis, gastric ulcer, chronic renal failure, chronic liver disease, anemia, asthma, diabetes mellitus.

Exclusion Criteria

  • Not provided

Investigators

Similar Trials